Codexis, Inc. (CDXS) Insider Trading Activity

NASDAQ$1.67
Market Cap
$150.84M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
50 of 893
Rank in Industry
40 of 510

CDXS Insider Trading Activity

CDXS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$9,701,893
34
74
Sells
$4,877,056
12
26

Related Transactions

Opaleye Management Inc.10 percent owner
34
$9.7M
7
$4.82M
$4.88M
De Vre Raymonddirector
0
$0
1
$2,459
$-2,459
Lutz StefanCSO
0
$0
1
$7,950
$-7,950
WOLF DENNIS Pdirector
0
$0
1
$13,988
$-13,988
Erbez GeorgiaChief Financial Officer
0
$0
1
$15,629
$-15,629
MOORE ALISONChief Technical Officer
0
$0
1
$15,629
$-15,629

About Codexis, Inc.

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Insider Activity of Codexis, Inc.

Over the last 12 months, insiders at Codexis, Inc. have bought $9.7M and sold $4.88M worth of Codexis, Inc. stock.

On average, over the past 5 years, insiders at Codexis, Inc. have bought $4.63M and sold $4.82M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $9.7M.

The last purchase of 780 shares for transaction amount of $2,211 was made by Opaleye Management Inc. (10 percent owner) on 2025‑08‑04.

List of Insider Buy and Sell Transactions, Codexis, Inc.

2026-01-07SaleLutz StefanCSO
4,685
0.0055%
$1.70
$7,950
-1.18%
2025-12-01SaleOpaleye Management Inc.10 percent owner
253,533
0.3021%
$1.67
$422,766
+1.52%
2025-11-28SaleOpaleye Management Inc.10 percent owner
107,490
0.1282%
$1.75
$188,108
-3.47%
2025-11-26SaleOpaleye Management Inc.10 percent owner
148,318
0.175%
$1.74
$258,266
-3.74%
2025-11-21SaleWOLF DENNIS Pdirector
8,952
0.0107%
$1.56
$13,988
+9.09%
2025-11-12SaleOpaleye Management Inc.10 percent owner
1.08M
1.4656%
$1.94
$2.1M
-13.86%
2025-11-11SaleOpaleye Management Inc.10 percent owner
548,211
0.6881%
$1.80
$986,451
-7.50%
2025-11-11SaleDe Vre Raymonddirector
1,413
0.0017%
$1.74
$2,459
-7.50%
2025-11-10SaleOpaleye Management Inc.10 percent owner
208,318
0.2521%
$1.73
$361,369
-4.86%
2025-11-07SaleOpaleye Management Inc.10 percent owner
296,682
0.2646%
$1.70
$503,410
-1.48%
2025-10-13SaleMOORE ALISONChief Technical Officer
6,239
0.0078%
$2.51
$15,629
-31.80%
2025-10-13SaleErbez GeorgiaChief Financial Officer
6,239
0.0078%
$2.50
$15,629
-31.80%
2025-08-04PurchaseOpaleye Management Inc.10 percent owner
780
0.001%
$2.83
$2,211
-14.79%
2025-07-31PurchaseOpaleye Management Inc.10 percent owner
84,220
0.1017%
$2.68
$225,710
-9.70%
2025-07-30PurchaseOpaleye Management Inc.10 percent owner
1,578
0.0019%
$2.79
$4,411
-13.26%
2025-07-29PurchaseOpaleye Management Inc.10 percent owner
8,422
0.0102%
$2.82
$23,750
-14.18%
2025-07-18PurchaseOpaleye Management Inc.10 percent owner
100,000
0.1207%
$2.82
$282,000
-13.48%
2025-06-27PurchaseOpaleye Management Inc.10 percent owner
100,000
0.1207%
$2.39
$239,000
+2.72%
2025-06-16PurchaseOpaleye Management Inc.10 percent owner
50,898
0.0614%
$2.24
$114,012
+9.38%
2025-06-13PurchaseOpaleye Management Inc.10 percent owner
99,102
0.1196%
$2.23
$220,997
+9.87%
Total: 250
*Gray background shows transactions not older than one year

Insider Historical Profitability

10.77%
Opaleye Management Inc.10 percent owner
179989
0.1993%
$300,581.63427
<0.0001%
MOORE ALISONChief Technical Officer
169332
0.1875%
$282,784.4401
WOLF DENNIS Pdirector
138951
0.1538%
$232,048.17023
Lutz StefanCSO
138775
0.1536%
$231,754.2501
De Vre Raymonddirector
87416
0.0968%
$145,984.7201
Erbez GeorgiaChief Financial Officer
70636
0.0782%
$117,962.1201
NICOLS JOHN Jdirector
783965
0.8679%
$1.31M431
<0.0001%
DILLY STEPHEN GEORGESee Remarks
438878
0.4859%
$732,926.2612
+69.19%
KELLEY BERNARD Jdirector
206136
0.2282%
$344,247.12016
SHAW ALANPresident and CEO
202000
0.2236%
$337,340.00112
+25.75%
Dorgan Byron Ldirector
193461
0.2142%
$323,079.8709
SANGSTER GORDONSVP & Chief Financial Officer
134453
0.1489%
$224,536.5108
Lalonde JamesSVP, R&D
133402
0.1477%
$222,781.34014
Ryali SriramChief Financial Officer
123441
0.1367%
$206,146.4710
+69.19%
O'Toole David DSVP & Chief Financial Officer
115384
0.1277%
$192,691.2840
<0.0001%
VIVO VENTURES VII, LLC10 percent owner
112940
0.125%
$188,609.8005
Norrett KevinChief Operating Officer
98102
0.1086%
$163,830.3412
+65.06%
Vivo Ventures Fund VII, L.P.10 percent owner
90330
0.1%
$150,851.1001
Fitzgerald Margaret NellSee Remarks
81420
0.0901%
$135,971.4012
+69.19%
Anton David L.SVP, BioIndustrials
70200
0.0777%
$117,234.0011
+25.75%
Sheehy Douglas T.SVP, General Counsel & Sec.
69200
0.0766%
$115,564.0011
+25.75%
Glaub Kathleen Seredadirector
63534
0.0703%
$106,101.7803
Cheng Pam P.director
58719
0.065%
$98,060.7302
Smith David Vdirector
56679
0.0628%
$94,653.9301
Lawson Robert JSVP and CFO
44000
0.0487%
$73,480.0020
<0.0001%
Yang Patrick Y
42512
0.0471%
$70,995.041212
+15.01%
BARUCH THOMAS Rdirector
33093
0.0366%
$55,265.31115
+28.81%
Pasternack Bruce Adirector
10000
0.0111%
$16,700.0030
+29.98%
Sarret Joseph J.CBO, President Pharmaceuticals
2000
0.0022%
$3,340.0010
+25.75%
CMEA VENTURES LIFE SCIENCES 2000 LP
0
0%
$001
Aldridge Michael D.See Remarks
0
0%
$002
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

Codexis, Inc.
(CDXS)
$6,578,958
42
10.77%
$150.84M
$48,218,096
42
0.89%
$135.07M
$16,259,194
41
120.51%
$168.04M
$7,147,964
34
24.78%
$146.64M
$1,323,997
34
0.21%
$157.79M
$18,752,549
33
-28.39%
$166.26M
$47,292,212
27
-28.21%
$158.53M
$295,092,700
21
-0.27%
$137.27M
$448,999,793
15
-19.99%
$144.9M
$245,302
15
-4.08%
$132.31M
$178,593,887
15
-14.86%
$145.86M
$4,701,608
14
-4.34%
$164.06M
$13,919,584
9
-30.43%
$174.6M
$22,090,972
7
-3.49%
$135.78M
$299,343
6
-44.75%
$136.46M
$556,839
5
13.42%
$159.44M
$6,049,986
4
-8.38%
$171.43M
$12,750
2
-39.73%
$170.09M
$19,175,155
2
40.00%
$144.38M

CDXS Institutional Investors: Active Positions

Increased Positions58+41.43%10M+14.61%
Decreased Positions55-39.29%15M-21.68%
New Positions23New2MNew
Sold Out Positions11Sold Out9MSold Out
Total Postitions143+2.14%66M-7.06%

CDXS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Opaleye Management Inc.$20,600.0014.22%12.79M+195,000+1.55%2025-09-30
Blackrock, Inc.$11,502.007.94%7.14M+8,010+0.11%2025-09-30
Vanguard Group Inc$7,518.005.19%4.67M+80,602+1.76%2025-09-30
Aberdeen Group Plc$6,588.004.55%4.09M-108,888-2.59%2025-09-30
Millennium Management Llc$6,549.004.52%4.07M+4M+3,376.49%2025-09-30
Nantahala Capital Management, Llc$6,489.004.48%4.03M00%2025-09-30
Telemark Asset Management, Llc$6,440.004.44%4M00%2025-09-30
Ameriprise Financial Inc$4,466.003.08%2.77M+222,840+8.74%2025-09-30
Geode Capital Management, Llc$3,208.002.21%1.99M+14,535+0.73%2025-09-30
Pier Capital, Llc$3,045.002.1%1.89M-23,928-1.25%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.